Tempest Therapeutics Nicholas Maestas Resigns As CFO Effective June 5, 2026; Appoints Justin Trojanowski As Principal Financial Officer Effective June 5, 2026

Benzinga Newsdesk www.benzinga.com Neutral 92.8%

Neg 0% Neu 92.8% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001544227/000119312526257684/d91703d8k.htm

Comments

No comments yet. Be the first!